HNC

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Retrieved on: 
목요일, 3월 28, 2024
Research, HNC, Symantec Endpoint Protection, Head, Type, Manganese, Chronic kidney disease, Incidence, ASN, CKD, New Drug Application, LAPC, Patient, Layoff, CRL, NDA, Cancer, Galera, Workforce, Pancreatic cancer, Clinical trial, Cisplatin, Society, Therapy, GRECO, File, Food, SOM, FDA, PDUFA, Pharmaceutical industry

We are continuing to explore strategic options to maximize value to our shareholders, including a potential development path for avasopasem.

Key Points: 
  • We are continuing to explore strategic options to maximize value to our shareholders, including a potential development path for avasopasem.
  • The Prescription Drug User Fee Act (PDUFA) target date assigned by the FDA for the NDA was August 9, 2023.
  • Research and development expenses were $3.2 million in the fourth quarter of 2023, compared to $8.1 million for the same period in 2022.
  • General and administrative expenses were $2.0 million in the fourth quarter of 2023, compared to $5.0 million for the same period in 2022.

Pearson and British Esports Federation Launch First Internationally Recognised Higher National BTEC Qualifications in Esports

Retrieved on: 
목요일, 3월 14, 2024
Primary, Secondary, Education, Sports, Other Education, General Sports, Continuing, University, Belfast Metropolitan College, BTEC, GEMS Education, Higher Nationals, Travel, AoC Beacon Awards, UTM, British Esports, HND, Sunderland College, Employment, PSON, Partnership, University of Salford, Ageing, Pleasure, Nottingham Trent University, Workforce, Creative, University of Chichester, York College, Digital, Real, Higher National Certificate, Key Stage 4, Queen Mary's College, Student, Gower College Swansea, University of Northampton, HNC, Growth, Sheffield Hallam University, ESAG, School, Higher education, Life, Vocational education, Level 4, Coventry College, Video game

British Esports, the UK’s national esports federation, and Pearson (FTSE: PSON,L), the world’s leading learning company, have launched a new suite of higher-tier BTEC qualifications in Esports - the first internationally available qualifications of their kind.

Key Points: 
  • British Esports, the UK’s national esports federation, and Pearson (FTSE: PSON,L), the world’s leading learning company, have launched a new suite of higher-tier BTEC qualifications in Esports - the first internationally available qualifications of their kind.
  • “This qualification is the perfect avenue to the top-up degree available from College of Esports for Level 6 and ultimately, Level 7.”
    For more information about the Higher National BTEC Qualifications in Esports, please visit the BTEC Higher Nationals in Esports .
  • These new qualifications, launching in 2024, complement Pearson and British Esports’ existing BTEC in Esports offering, including the Level 2 Skills in Esports BTEC for Key Stage 4 students, and the Level 3 BTEC Nationals in Esports for students aged 16+.
  • The BTEC Higher National qualifications are widely recognised by industry and higher education authorities around the world as the principal technical professional qualification at this level.

Pearson and British Esports Federation Launch First Internationally Recognised Higher National BTEC Qualifications in Esports

Retrieved on: 
목요일, 3월 14, 2024
Belfast Metropolitan College, University, BTEC, GEMS Education, Higher Nationals, Travel, AoC Beacon Awards, UTM, British Esports, HND, Sunderland College, Employment, Education, PSON, Partnership, University of Salford, Ageing, Pleasure, Nottingham Trent University, Workforce, Creative, University of Chichester, York College, Digital, Real, Higher National Certificate, Key Stage 4, Queen Mary's College, Level 7, Student, Gower College Swansea, University of Northampton, HNC, Growth, Sheffield Hallam University, ESAG, School, Higher education, Life, Vocational education, Level 4, Coventry College, Video game

LONDON, March 14, 2024 /PRNewswire/ -- British Esports, the UK's national esports federation, and Pearson (FTSE: PSON,L), the world's leading learning company, have launched a new suite of higher-tier BTEC qualifications in Esports - the first internationally available qualifications of their kind.

Key Points: 
  • LONDON, March 14, 2024 /PRNewswire/ -- British Esports, the UK's national esports federation, and Pearson (FTSE: PSON,L), the world's leading learning company, have launched a new suite of higher-tier BTEC qualifications in Esports - the first internationally available qualifications of their kind.
  • For more information about the Higher National BTEC Qualifications in Esports, please visit the BTEC Higher Nationals in Esports .
  • These new qualifications, launching in 2024, complement Pearson and British Esports' existing BTEC in Esports offering, including the Level 2 Skills in Esports BTEC for Key Stage 4 students, and the Level 3 BTEC Nationals in Esports for students aged 16+.
  • The BTEC Higher National qualifications are widely recognised by industry and higher education authorities around the world as the principal technical professional qualification at this level.

Pearson and British Esports Federation Launch First Internationally Recognised Higher National BTEC Qualifications in Esports

Retrieved on: 
목요일, 3월 14, 2024
Belfast Metropolitan College, University, BTEC, GEMS Education, Higher Nationals, Travel, AoC Beacon Awards, UTM, British Esports, HND, Sunderland College, Employment, Education, PSON, Partnership, University of Salford, Ageing, Pleasure, Nottingham Trent University, Workforce, Creative, University of Chichester, York College, Digital, Real, Higher National Certificate, Key Stage 4, Queen Mary's College, Level 7, Student, Gower College Swansea, University of Northampton, HNC, Growth, Sheffield Hallam University, ESAG, School, Higher education, Life, Vocational education, Level 4, Coventry College, Video game

LONDON, March 14, 2024 /PRNewswire/ -- British Esports, the UK's national esports federation, and Pearson (FTSE: PSON,L), the world's leading learning company, have launched a new suite of higher-tier BTEC qualifications in Esports - the first internationally available qualifications of their kind.

Key Points: 
  • LONDON, March 14, 2024 /PRNewswire/ -- British Esports, the UK's national esports federation, and Pearson (FTSE: PSON,L), the world's leading learning company, have launched a new suite of higher-tier BTEC qualifications in Esports - the first internationally available qualifications of their kind.
  • For more information about the Higher National BTEC Qualifications in Esports, please visit the BTEC Higher Nationals in Esports .
  • These new qualifications, launching in 2024, complement Pearson and British Esports' existing BTEC in Esports offering, including the Level 2 Skills in Esports BTEC for Key Stage 4 students, and the Level 3 BTEC Nationals in Esports for students aged 16+.
  • The BTEC Higher National qualifications are widely recognised by industry and higher education authorities around the world as the principal technical professional qualification at this level.

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Retrieved on: 
목요일, 2월 15, 2024
Closing, Neoplasm, Algorithm, Recurrence, Epigenomics, Oxford Nanopore Technologies, Doctor of Philosophy, LOS, LON, AI, MD, Blood, LOI, Partnership, Cancer, Lung cancer, Liquid biopsy, TP53, Cell, Metabolomics, Diagnosis, Triple-negative breast cancer, Physical examination, Carcinoma, Patient, Proteomics, Genomics, Deep learning, HNC, Nvidia, DNA, IVD, NVIDIA, Medical imaging

LOS ANGELES and AMSTERDAM, Feb. 15, 2024 (GLOBE NEWSWIRE) -- GEDiCube (moving forward RenovaroCube), a London and Netherlands-based advanced AI company and a wholly owned subsidiary of Renovaro Inc. (NASDAQ: RENB), announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics, a Dutch Company. Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.

Key Points: 
  • Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single vial of blood.
  • Cyclomics’ 4th generation liquid biopsy genomics platform is the first truly “Omni-Omic” blood test ready for AI application.
  • Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.
  • The focus is on early cancer- and early recurrence detection, prediction of response to therapy, and personalized treatment, all via liquid biopsy tests.

dsm-firmenich reports full year 2023 results

Retrieved on: 
목요일, 2월 15, 2024
DSM, ANH, Nutrition, Firmenich, Animal nutrition, Vitamin, Culture, Beauty, TTH, Life, Climate change, Element, Acceleration, Science, Annual, HNC, Fine chemical

2 Represents the figures on an IFRS basis, including the Firmenich results as of the merger date May 8, 2023.

Key Points: 
  • 2 Represents the figures on an IFRS basis, including the Firmenich results as of the merger date May 8, 2023.
  • We accelerated our plans for driving through additional self-help measures and advanced the review of all our business segments.
  • In Q4 2023, the program generated an about €10 million savings contribution to Adjusted EBITDA.
  • At the Annual General Meeting on May 7, 2024, dsm-firmenich's Board of Directors will propose a cash dividend of €2.50 per share for the financial year 2023.

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Retrieved on: 
화요일, 2월 13, 2024
Closing, Neoplasm, Algorithm, Recurrence, Epigenomics, Oxford Nanopore Technologies, Doctor of Philosophy, LOS, LON, MD, Blood, LOI, Partnership, Cancer, Lung cancer, Liquid biopsy, TP53, Cell, Metabolomics, Diagnosis, Triple-negative breast cancer, Physical examination, Carcinoma, Patient, Proteomics, Genomics, Deep learning, HNC, Nvidia, DNA, IVD, NVIDIA, Medical imaging

LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) -- GEDi Cube Intl Ltd., a London and Netherlands-based advanced AI company and a wholly owned subsidiary of Renovaro Inc. (NASDAQ: RENB), announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics, a Dutch Company. Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.

Key Points: 
  • Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single vial of blood.
  • The combined Companies aim to Disrupt Cancer Diagnosis and treatment through early disease and recurrence detection, prediction of response to treatment, and personalized therapy.
  • Under the terms of the LOI, the parties have agreed to work in good faith on the drafting of a definitive agreement.
  • I consider that to be a significant step towards bringing early detection of cancer to its inflection point.”

Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial

Retrieved on: 
화요일, 2월 13, 2024
Neoplasm, Head and neck cancer, Cetuximab, Toxicity, Doctor of Philosophy, Research fellow, Immunotherapy, SAB, University, Health, Associate, HNC, Neck, Assistant, Escape Room, SCCHN, Moores Cancer Center, Associate professor, Focus group, Oncology, Immunity, Metastasis, Biomarker, Science, Tumor microenvironment, Communication, Division, Drug resistance, MD, Lead, Patient, Publication, Cancer, Pharmaceutical industry

REHOVOT, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) --  Purple Biotech Ltd.("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced it convened a Scientific Advisory Board (SAB) focusing the discussions on NT219’s indication in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).

Key Points: 
  • “Their recognition of the critical unmet need in recurrent and metastatic head and neck cancer provides further support and momentum to our development program.
  • Now that we have determined the recommended Phase 2 dose, we are prepared to move to our next phase of development.
  • We look forward to the head and neck cancer SAB’s continued guidance and support.”
    Head & Neck Cancer SAB Members Include:
    Douglas Adkins, MD – Dr. Adkins is a Professor of Medicine and Director, Head and Neck and Thyroid Medical Oncology, at the Siteman Cancer Center, Washington University School of Medicine.
  • He is a nationally recognized expert in head and neck cancer known for his commitment to advancing patient care through clinical research.

DINER EN NOIR WORLDWIDE PARTNERS WITH AEG TV NETWORK & THE HNC AGENCY TO ELEVATE BLACK-OWNED BUSINESSES AND BRANDS

Retrieved on: 
목요일, 2월 8, 2024
Flagship, 1,000,000, Small business, Roku, Culture, Partnership, AEG, Growth, OS, Health, Heart, HNC, Creativity, FIRST, Marketing, Sirius XM, Black History Month, Advertising, Economic development

WASHINGTON, Feb. 8, 2024 /PRNewswire/ -- Dîner en Noir Worldwide proudly announces an innovative partnership with AEG TV Network and The HNC Agency, marking a significant milestone in its commitment to uplifting black-owned businesses and brands.

Key Points: 
  • WASHINGTON, Feb. 8, 2024 /PRNewswire/ -- Dîner en Noir Worldwide proudly announces an innovative partnership with AEG TV Network and The HNC Agency, marking a significant milestone in its commitment to uplifting black-owned businesses and brands.
  • As we celebrate Black History Month, Dîner en Noir Worldwide continues to lead the charge as the FIRST BLACK-OWNED international organization in the realms of fine dining, event production, and professional member benefits.
  • AEG TV Network, a premier entertainment platform dedicated to celebrating diversity, culture, and creativity, stands as a formidable ally in this endeavor.
  • Joining forces with The HNC Agency , a Washington, DC powerhouse since 2008, Dîner en Noir Worldwide extends their services to its members through discounted al la carte services and comprehensive plans.

Kallisio Patient-tailored Oral Stent for Head and Neck Cancer (HNC) Treatment Receives FDA Clearance

Retrieved on: 
목요일, 1월 18, 2024
FDA, Health, Oncology, Medical Devices, Patient, Monroe Dunaway Anderson, Associate, Radiation, MD Anderson Cancer Center, HNC, Risk, 3D, IMRT, Tongue, University, Toxicity, Oar, Medical imaging

Kallisio , focused on developing solutions to manage toxicity in cancer care, announces FDA 510(k) clearance for Stentra, an individually tailored 3D printed oral stent solution designed to protect healthy tissue in Head and Neck Cancer (HNC) patients.

Key Points: 
  • Kallisio , focused on developing solutions to manage toxicity in cancer care, announces FDA 510(k) clearance for Stentra, an individually tailored 3D printed oral stent solution designed to protect healthy tissue in Head and Neck Cancer (HNC) patients.
  • Customized for each patient, the Stentra oral immobilization stent effectively directs radiation to the target tumor area while reducing harmful impact to surrounding tissue.
  • By integrating patient oral data with advanced 3D printing, Stentra is meticulously tailored to mitigate target positioning discrepancies associated with radiotherapy methods like IMRT (intensity-modulated radiation therapy).
  • A Stentra device immobilizes tongue, lips, and other OARs (organs at risk), keeping them clear of the high-dose radiation target zone.